Clinical Trials Browser

Phase 1 × Peripheral Nervous System Diseases × enfortumab vedotin × Clear all

NCT07484022 2026-06-03

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

Phase 1 Recruiting

Carcinoma, Transitional Cell, Peripheral Nervous System Diseases